These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7705194)

  • 21. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects.
    Tanaka Y; Atsumi Y; Asahina T; Hosokawa K; Matsuoka K; Kinoshita J; Onuma T; Kawamori R
    Diabetes Care; 1998 Jul; 21(7):1133-7. PubMed ID: 9653608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Features of insulin secretion and insulin resistance in newly diagnosed type 2 diabetes of different body mass indices].
    An YL; Gao Y; Zhu Q; Ning G; Jia WP; Huang Q; Xu W; Li CJ; Zhou ZG; Shi BY; Shan ZY; Chen LL; Xu ZR; Wang H; Yan L; Zhong HJ; Ji QH; Li H; Xue YM; Zhing MX; Gu W; Guo XH; Gao LL; Hong J; Liu F; Zou DJ; Li YB; Zhang XY; Li Z; Guo G; Zhao XJ; Wu HN; Wang YZ; Zhao WG; Zhang SL; Wu J; Zhang NY; Yang FY; Zhang Y; Zhou XR; Ren YZ; Li GW
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1117-21. PubMed ID: 19595144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial.
    Hammersley MS; Meyer LC; Morris RJ; Manley SE; Turner RC; Holman RR
    Metabolism; 1997 Dec; 46(12 Suppl 1):44-9. PubMed ID: 9439559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
    Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
    Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasting plasma glucose in screening for NIDDM in the U.S. and Israel.
    Modan M; Harris MI
    Diabetes Care; 1994 May; 17(5):436-9. PubMed ID: 7741837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure.
    Cruickshank JK; Cooper J; Burnett M; MacDuff J; Drubra U
    Lancet; 1991 Oct; 338(8771):842-7. PubMed ID: 1681214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of family history of diabetes on the assessment of beta-cell function.
    Alford FP; Henriksen JE; Rantzau C; Vaag A; Hew LF; Ward GM; Beck-Nielsen H
    Metabolism; 1998 May; 47(5):522-8. PubMed ID: 9591741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
    Simonson DC; Ferrannini E; Bevilacqua S; Smith D; Barrett E; Carlson R; DeFronzo RA
    Diabetes; 1984 Sep; 33(9):838-45. PubMed ID: 6432610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patients.
    Willms B; Idowu K; Holst JJ; Creutzfeldt W; Nauck MA
    Exp Clin Endocrinol Diabetes; 1998; 106(2):103-7. PubMed ID: 9628239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes.
    Mari A; Tura A; Pacini G; Kautzky-Willer A; Ferrannini E
    Diabet Med; 2008 Jun; 25(6):671-7. PubMed ID: 18544104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S69-78. PubMed ID: 1794269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of middle-term gliclazide treatment on insulin secretion in non-insulin dependent diabetics.
    Brogard JM; Pinget M; Dorner M
    Curr Med Res Opin; 1984; 9(1):56-63. PubMed ID: 6373160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two?
    Tfayli H; Bacha F; Gungor N; Arslanian S
    Diabetes Care; 2010 Mar; 33(3):632-8. PubMed ID: 20028940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
    Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
    J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood ketone bodies in NIDDM: relationship with diabetic control and endogenous insulin secretion.
    Suzuki M; Kosegawa I; Miura S; Negishi K; Itabashi A; Katayama S; Ishii J; Kamata S; Fujita C
    Diabetes Res; 1991 Sep; 18(1):11-7. PubMed ID: 1823641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.